Facial nerve schwannomas (FNSs) are rare benign tumors arising from the Schwann cells of the sheath of the facial nerve. These tumors may arise anywhere along the course of the facial nerve. Owing to their rarity and nonspecific clinical and radiological presentations, the preoperative diagnosis of FNSs is exceedingly difficult. In this study, we present four cases of histopathologically proven extratemporal schwannomas and a solitary case of intratemporal schwannoma. The purpose of this study was mainly focused on analyzing the imaging findings of extratemporal and intratemporal schwannomas in an effort to better characterize these lesions preoperatively. An early diagnosis of FNSs is helpful for the management and rehabilitation of these cases.
Burst fracture of C5 with traumatic anterior spondyloptosis of C6 and posterior spondylolisthesis of C4 vertebra is an exceedingly rare high energy injury. Treatment includes decompression, reduction, stabilization, and fusion via anterior or posterior or combined anterior-posterior approach with or without prior traction. We report this rare subaxial cervical spine injury associated with quadriplegia managed with combined anterior and posterior instrumented fusion. A multidisciplinary approach with preoperative assessment and planning is crucial in managing cervical spine injury. Immediate postoperative critical care support, rehabilitation, and dedicated nursing care are required for a favorable outcome in traumatic quadriplegia.
Background: Our study investigated the effects of IOC2 index monitoring on remifentanil dosage during desflurane anesthesia. The objective of this study was to compare the intra-operative events and recovery characteristics between remifentanil adjusted by IOC2 monitoring guidelines versus remifentanil adjusted by clinical experience according to fluctuation in blood pressure and heart rate during desflurane anesthesia. Methods: Total of 50 consecutive patients of American Society of Anesthesiologists (ASA) status I and II, aged 18-65 years, BMI 18-30 kg/m2 undergoing elective laparoscopic cholecystectomy under desflurane anesthesia were enrolled. The patients were randomized and allocated into 2 groups, group T (Trial group=25) and group C (control group=25) using sealed envelope method. The infusion rate of remifentanil was adjusted according to IOC2 monitoring guideline between 30 to 50 in Group T whereas the infusion rate of remifentanil is adjusted by clinical experience according to fluctuation in blood pressure in group C. Remifentanil dose, adjustment frequency, infusion duration, intraoperative events, and quality of anesthetic recovery were compared between the two groups. Results: Mean dose as well as the adjustment frequency of remifentanil was significantly higher in group T in compared with group C (0.1376±0.0268 vs 0.0956±0.0223 mcg/kg/min and 5.19±1.97vs1.7±0.57 times/surgery, P<0.05). IOC2 value at the time of skin incision, at the time of gall bladder resection and at the time of skin suture was significantly different between two groups (all P value <0.05). Although apparent differences in frequencies of hypotension, bradycardia, hypertension, the total number of patents with intraoperative events were not statistically different between two groups (all P > 0.05). Both groups had similar voluntary eye opening time, extubation time, emergence agitation ,residual sedation 1 and 10 minutes after extubation, post-operative vomiting and NRS score (in PACU and 24 hours after extubation (all P > 0.05). Conclusion: IOC2 data was significantly high when opioid adjusted by clinical experience. The dose of opioid used according to IOC2 (30-50) monitoring guideline utilized higher dose in compared with dose used by clinical experience however, the intraoperative hemodynamic and recovery characteristics was unchanged. Hence, application of IOC2 monitoring might be beneficial to adjust the analgesic depth.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.